BR9908443A - Linhagens de células de medula espinhal humana e métodos para uso das mesmas - Google Patents

Linhagens de células de medula espinhal humana e métodos para uso das mesmas

Info

Publication number
BR9908443A
BR9908443A BR9908443-0A BR9908443A BR9908443A BR 9908443 A BR9908443 A BR 9908443A BR 9908443 A BR9908443 A BR 9908443A BR 9908443 A BR9908443 A BR 9908443A
Authority
BR
Brazil
Prior art keywords
cell lines
spinal cord
methods
human spinal
cells
Prior art date
Application number
BR9908443-0A
Other languages
English (en)
Inventor
Ronghao Li
Dinah W Y Sah
Original Assignee
Signal Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Signal Pharm Inc filed Critical Signal Pharm Inc
Publication of BR9908443A publication Critical patent/BR9908443A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"LINHAGENS DE CéLULAS DE MEDULA ESPINHAL HUMANA E MéTODOS PARA USO DAS MESMAS". A presente invenção refere-se a linhagens de células de medula espinhal humana condicionalmente imortalizadas. Tais linhagens de células, que podem ser clonais, podem ser usadas para gerar neurónios, incluindo motoneurónios. As linhagens de células e/ou células diferenciadas podem ser usadas para o desenvolvimento de agentes terapêuticos para prevenir e tratar uma variedade de doenças e ferimentos relacionadas a medula espinhal. As linhagens de células e/ou células diferenciadas podem ser usadas em ensaios e para o estudo geral do desenvolvimento e direferenciação de células de medula espinhal.
BR9908443-0A 1998-03-02 1999-03-02 Linhagens de células de medula espinhal humana e métodos para uso das mesmas BR9908443A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7656798P 1998-03-02 1998-03-02
US09/059,790 US6225122B1 (en) 1998-03-02 1998-04-13 Human spinal cord cell lines and methods of use therefor
PCT/US1999/004535 WO1999045103A2 (en) 1998-03-02 1999-03-02 Human spinal cord cell lines and methods of use therefor

Publications (1)

Publication Number Publication Date
BR9908443A true BR9908443A (pt) 2002-01-15

Family

ID=26739180

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908443-0A BR9908443A (pt) 1998-03-02 1999-03-02 Linhagens de células de medula espinhal humana e métodos para uso das mesmas

Country Status (7)

Country Link
US (1) US6225122B1 (pt)
EP (1) EP1060245A2 (pt)
CN (1) CN1297477A (pt)
AU (1) AU3065599A (pt)
BR (1) BR9908443A (pt)
CA (1) CA2322747A1 (pt)
WO (1) WO1999045103A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037493B2 (en) 2000-05-01 2006-05-02 Cornell Research Foundation, Inc. Method of inducing neuronal production in the brain and spinal cord
US20030077564A1 (en) * 2001-10-02 2003-04-24 Board Of Trustees Of Southern Illinois University Nutrient medium for maintaining neural cells in injured nervous system
US6770521B2 (en) * 2001-11-30 2004-08-03 Texas Instruments Incorporated Method of making multiple work function gates by implanting metals with metallic alloying additives
WO2003050273A1 (fr) * 2001-12-13 2003-06-19 Japan Science And Technology Agency Milieu de culture pour des cellules humaines et methode de culture
AU2003215297A1 (en) * 2002-02-15 2003-09-09 Cornell Research Foundation, Inc. Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
WO2006138718A2 (en) * 2005-06-17 2006-12-28 Drexel University Three-dimensional scaffolds for tissue engineering made by processing complex extracts of natural extracellular matrices
WO2015017354A1 (en) * 2013-07-29 2015-02-05 University Of Houston System Volatile organic gases as bioindicators for transplant rejection
US11156595B2 (en) * 2015-05-28 2021-10-26 Axogen Corporation Organotypic DRG-peripheral nerve culture system
EP3332695B1 (en) * 2016-12-09 2021-05-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Measurement device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222040B1 (hu) 1994-11-08 2003-04-28 Cellfactors Plc Eljárás humán porc, csont és neurális sejtvonalak előállítására
US5770414A (en) 1996-02-20 1998-06-23 The Regents Of The University Of California Regulatable retrovirus system for genetic modification of cells
US6713247B1 (en) 1996-09-03 2004-03-30 Signal Pharmaceuticials, Inc. Human CNS cell lines and methods of use therefor

Also Published As

Publication number Publication date
CA2322747A1 (en) 1999-09-10
WO1999045103A2 (en) 1999-09-10
AU3065599A (en) 1999-09-20
EP1060245A2 (en) 2000-12-20
CN1297477A (zh) 2001-05-30
US6225122B1 (en) 2001-05-01
WO1999045103A3 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
BR9912007A (pt) Composições e métodos para terapia e diagnóstico de câncer de próstata
BR0012069A (pt) Composições e métodos para a terapia e diagnóstico de câncer pulmonar
ATE251140T1 (de) N-(2 oxoacetyl oder sulphonyl)- pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
ATE517125T1 (de) ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN
BR0009537A (pt) Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
BR0315688A (pt) Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
SE9500566L (sv) L-platta
EP0554383A4 (pt)
ES2163034T3 (es) Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana.
BR9909624A (pt) Linhagens de células do sistema nervoso periférico (pns) e processos de utilização para as memas
ATE221881T1 (de) Tetralin-verbindungen mit multi-drugresistenz (mdr)-aktivitat
BR0110091A (pt) Composições e processos para terapia e diagnóstico de câncer de mama
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
WO2003004045A3 (en) Methods for identifying therapeutic agents for treating diseases involving wnt polypeptides and wnt receptors
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
BR9808606A (pt) Materiais e métodos para tratamento de doenças com ribozimas
BR9908443A (pt) Linhagens de células de medula espinhal humana e métodos para uso das mesmas
DK0969822T3 (da) Bestemmelse af et organs eller vævs tilbøjelighed til cancer ved bestemmelse af dets prægningsmønster
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
HK1025793A1 (en) Hepatitis c receptor protein cd81
TR200001486T2 (tr) Hiperkeratozlu deri hastalıklarının tedavisi için diol ve alfa-hidroksi asitten oluşan bir karışımın kullanılması
PT841939E (pt) Agentes terapeuticos e doencas auto-imunes
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired